Medical water-soluble cannabidiol CBD preparation formula

Abstract

The invention relates to a medical water-soluble cannabisdiol CBD preparation formula. The preparation is prepared from, by weight, 60-80 parts of water-soluble cannabisdiol CBD, 5-10 parts of water-soluble hypocannabidiol CBDa, 1-3 parts of and water-soluble cannabigerol CBG, 1-5 parts of water-soluble cannabis Elson CBE, 2-3 parts of water-soluble cannabis color CBC and 5-8 parts of water-soluble CBN. Compared with the prior art, the formula has the advantages that the water-soluble cannabisdiol CBD serves as the main component, does not contain addictive ingredients, has no psychoactive activity, does not produce dependence, and repairs cells and neuronal systems, and meanwhile the pharmacological action is achieved for resisting spasticity, anxiety, neurogenic diseases, pain and cancer; the preparation can be made to be effervescent tablets, dissolved medicines, capsules, soft capsules, tablets, sprays, emulsified oils, creams, transdermal patches, suppositories, expectorant tablets and sprays, the bioavailability is high, and the formula can play a good effect on cell repair of postoperative chemotherapy and radiotherapy for cancer and treatment of neuropathic diseases.

Description

【Technical field】 [0001] The invention relates to the technical field of medicine, in particular to a medical water-soluble cannabidiol CBD formulation. 【Background technique】 [0002] The incidence of cancer is increasing, the treatment methods are traditional, and the side effects of chemotherapy and radiotherapy after surgery are large. Nausea, anxiety, irritability, anorexia, hair loss, hand shaking and weakness, mental stress, anxiety and depression, muscle pain and insomnia can be seen everywhere, and the quality of life is low. . At the same time, neurodegenerative diseases are a kind of diseases with slow onset, progressive development and poor prognosis. So far, there is no effective cure method. The common clinical neurodegenerative diseases include Parkinson's disease (Parkinson's disease, PD), muscular atrophy Lateral sclerosis (amyotrophic lateral sclerosis, ALS), Huntington's disease (HD) and Alzheimer's disease (AD) autism autism, also known as autism or auti...

AI Technical Summary

Problems solved by technology

[0003] Most of the existing drugs for the treatment of the above diseases are placebos and tranquilizers, with many side effects, long-term use can produce dependence, drug resistance and drug resistance, and the effect is not obvious or the development of the disease cannot be effectively controlled. The above are the existing defects

More importantly, the existing cannabidiol CBD substances are insoluble in water, have low bioavailability, cannot fully exert their medicinal effects, and affect the therapeutic effect